Published in:
Open Access
01-12-2006 | Case report
Gitelman-like syndrome after cisplatin therapy: a case report and literature review
Authors:
Kessarin Panichpisal, Freddy Angulo-Pernett, Sharmila Selhi, Kenneth M Nugent
Published in:
BMC Nephrology
|
Issue 1/2006
Login to get access
Abstract
Background
Cisplatin is a well-known nephrotoxic antineoplastic drug. Chronic hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria is one of the rare complications associated with its use.
Case presentation
A 42- year-old woman presented with a 20 year-history of hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria after cisplatin-based chemotherapy for ovarian cancer. This patient has had chronic muscle aches and fatigue and has had episodic seizure-like activity and periodic paralysis. Only thirteen other patients with similar electrolyte abnormalities have been described in the literature. This case has the longest follow-up.
Conclusion
Cisplatin can cause permanent nephrotoxicity, including Gitelman-like syndrome. This drug should be considered among the possible causes of chronic unexplained electrolyte disorders.